by Truveta staff | Nov 16, 2023 | Data
In the world of healthcare, few conditions have seen as much transformation over the past decade as diabetes. With 37.3 million Americans living with diabetes, and a further 96 million in the prediabetes stage, it’s a life-altering health concern for nearly 40% of the...
by Truveta staff | Nov 8, 2023 | Data, News, Technology
When I had the first conversations about creating Truveta, I knew technology was the answer to solving healthcare data challenges. Healthcare data traditionally has been too siloed, inaccessible, and messy to be useful for research. And one of the biggest challenges...
by Truveta staff | Nov 1, 2023 | Data
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
by Truveta staff | Oct 26, 2023 | Data
Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have received a diagnosis of liver disease, a far larger yet largely unaware group is treading...
by Truveta staff | Oct 2, 2023 | Data
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...
by Truveta staff | Sep 22, 2023 | Data
Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4 million (3M adults and 470,000 children) have active epilepsy in the US. These seizures...
